Your browser doesn't support javascript.
loading
SPAG7 deletion causes intrauterine growth restriction, resulting in adulthood obesity and metabolic dysfunction.
Flaherty, Stephen E; Bezy, Olivier; Paulhus, Brianna LaCarubba; Song, LouJin; Piper, Mary; Pang, Jincheng; Park, Yoson; Asano, Shoh; Lien, Yu-Chin; Griffin, John D; Robertson, Andrew; Opsahl, Alan; Shanthappa, Dinesh Hirenallur; Ahn, Youngwook; Pashos, Evanthia; Simmons, Rebecca A; Birnbaum, Morris J; Wu, Zhidan.
Afiliación
  • Flaherty SE; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Bezy O; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Paulhus BL; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Song L; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Piper M; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Pang J; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Park Y; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Asano S; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Lien YC; Center for Research on Reproduction and Women's Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
  • Griffin JD; Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, United States.
  • Robertson A; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Opsahl A; Drug Safety Research and Development, Pfizer Inc, Groton, United States.
  • Shanthappa DH; Drug Safety Research and Development, Pfizer Inc, Groton, United States.
  • Ahn Y; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Pashos E; Medicine Design, Pfizer Inc, Cambridge, United States.
  • Simmons RA; Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States.
  • Birnbaum MJ; Center for Research on Reproduction and Women's Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
  • Wu Z; Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, United States.
Elife ; 122024 Jul 26.
Article en En | MEDLINE | ID: mdl-39056292
ABSTRACT
From a forward mutagenetic screen to discover mutations associated with obesity, we identified mutations in the Spag7 gene linked to metabolic dysfunction in mice. Here, we show that SPAG7 KO mice are born smaller and develop obesity and glucose intolerance in adulthood. This obesity does not stem from hyperphagia, but a decrease in energy expenditure. The KO animals also display reduced exercise tolerance and muscle function due to impaired mitochondrial function. Furthermore, SPAG7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental insufficiency, likely due to abnormal development of the placental junctional zone. This insufficiency leads to loss of SPAG7-deficient fetuses in utero and reduced birth weights of those that survive. We hypothesize that a 'thrifty phenotype' is ingrained in SPAG7 KO animals during development that leads to adult obesity. Collectively, these results indicate that SPAG7 is essential for embryonic development and energy homeostasis later in life.
Obesity rates are climbing worldwide, leading to an increase in associated conditions such as type 2 diabetes. While new pharmaceutical approaches are available to help individuals manage their weight, many patients do not respond to them or experience prohibitive side effects. Identifying alternative treatments will likely require pinpointing the genes and molecular actors involved in the biological processes that control weight regulation. Previous research suggests that a protein known as SPAG7 could help shape how mice use and store the energy they extract from food. Flaherty et al. therefore set out to investigate the role this protein plays in the body. To do so, they created a line of mice born without SPAG7, which they monitored closely throughout life. These animals were underweight at birth and did not eat more than other mice, yet they were obese as adults. Their ability to exercise was reduced, their muscles were weaker and contained fibers with functional defects. The mice also exhibited biological changes associated with the onset of diabetes. Yet deleting SPAG7 during adulthood led to no such changes; these mice maintained normal muscle function and body weight. Closely examining how SPAG7-deficient mice developed in the womb revealed placental defects which likely caused these animals to receive fewer nutrients from their mother. Such early-life deprivation is known to be associated with the body shifting towards maximizing its use of resources and privileging fat storage, even into and throughout adulthood. By shedding light on the biological role of SPAG7, the work by Flaherty et al. helps to better understand how developmental events can increase the likelihood of obesity later in life. Further investigations are now needed to explore whether this knowledge could help design interventions relevant to human health.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ratones Noqueados / Retardo del Crecimiento Fetal / Obesidad Límite: Animals / Pregnancy Idioma: En Revista: Elife Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ratones Noqueados / Retardo del Crecimiento Fetal / Obesidad Límite: Animals / Pregnancy Idioma: En Revista: Elife Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos